How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,836 results for

Wart Treatment

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02377999 Recruitment Status : Completed First Posted : March 4, 2015 Last Update Posted : May 3, 2017 Sponsor: LEO Pharma Information

2015 Clinical Trials

142. A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital warts. (Abstract)

A single-blinded randomized controlled study to assess the efficacy of twice daily application of sinecatechins 15% ointment when used sequentially with cryotherapy in the treatment of external genital warts. To evaluate the efficacy of sequential therapy of cryotherapy and sinecatechins 15% ointment BID versus cryotherapy alone in treatment of external genital warts (EGW).Forty-two subjects with at least two EGW lesions underwent cryotherapy to all lesions. One week following cryotherapy (...) , subjects were randomized 1:1 to receive either no additional treatment or treatment with sinecatechins 15% ointment BID up to 16 weeks or until complete clearance. The total number of visible baseline and new EGW were recorded at each visit. Subjects were followed for a total of 65 weeks post-treatment.There was a significant reduction in mean number of lesions from baseline after 16 weeks of treatment in the cryotherapy-sinecatechins ointment group compared to cryotherapy alone (-5.0 lesions vs -2.1

2015 Journal of drugs in dermatology : JDD Controlled trial quality: uncertain

143. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. (Abstract)

Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Intralesional purified protein derivative (PPD) or mumps, measles, rubella (MMR) were not previously compared regarding their efficacy or mechanism of action in treatment of warts. We aimed to compare their efficacy in treatment of multiple warts and investigate their effect on serum interleukin (IL)-4 and IL-12. Thirty patients (...) with multiple warts were included (10 treated with PPD, 10 with MMR, and 10 with normal saline (control)). Injection was done every 3 weeks until clearance or maximum of three treatments. Clinical response of target and distant warts was evaluated. Serum ILs-4 and -12 were assessed before and after treatment. A significantly higher rate of complete response was found in target and distant warts with PPD (60% each) and MMR (80%, 40%, respectively) compared with controls (0%), with no significant difference

2015 Dermatologic therapy Controlled trial quality: uncertain

144. Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02567149 Recruitment Status : Withdrawn (No funding) First Posted : October

2015 Clinical Trials

145. Nanopulse Efficacy Study for the Treatment of Common Warts

Nanopulse Efficacy Study for the Treatment of Common Warts Nanopulse Efficacy Study for the Treatment of Common Warts - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Nanopulse Efficacy Study (...) for the Treatment of Common Warts The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02650466 Recruitment Status : Completed First Posted : January 8, 2016 Last Update Posted : March 29, 2017 Sponsor: University of Southern California Information provided by (Responsible Party): Stefani Takahashi, University

2015 Clinical Trials

146. Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02393417 Recruitment Status : Completed First Posted : March 19, 2015 Last Update Posted : April 17, 2018

2015 Clinical Trials

147. Quadrivalent Human Papillomavirus Vaccination: A Promising Treatment for Recalcitrant Cutaneous Warts in Children. Full Text available with Trip Pro

Quadrivalent Human Papillomavirus Vaccination: A Promising Treatment for Recalcitrant Cutaneous Warts in Children. 25824471 2016 08 12 2015 11 04 1651-2057 95 8 2015 Nov Acta dermato-venereologica Acta Derm. Venereol. Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children. 1017-9 10.2340/00015555-2111 Abeck Dietrich D Group practice for Dermatology and Allergology, , Munich, Germany. professorabeck@mytum.de. Fölster-Holst Regina R eng (...) Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 0 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 IM Child Female Foot Dermatoses drug therapy Hand Dermatoses drug therapy Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 therapeutic use Humans Male Retreatment Warts drug therapy 2015 4 1 6 0 2015 4 1 6 0 2016 8 16 6 0 ppublish 25824471 10.2340/00015555-2111

2015 Acta Dermato-Venereologica

148. Plantar Wart

(pared) Painless on lateral pressure Retain normal fingerprint lines (warts do not) Contrast with pinpoint blood vessels of Plantar Warts Foreign body reaction (sheering in sports) Epithioma cuniculatum (verrucous carcinoma) IX. Precautions No treatment needed if asymptomatic Avoid aggressive technique Surgical excision X. Management ral Topical treatments require 2-3 months for eradication Relieve pressure on wart area with pads Soak foot before application of salicylic acid Soak in warm water (...) years without treatment Recurrence after treatment is common XIII. References Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Plantar Wart." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Plantar wart (C0042548) Definition (NCI) A wart in the plantar surface of the foot. It is caused by human papillomavirus. Concepts Disease or Syndrome ( T047

2018 FP Notebook

149. Genital Wart

-related malignancy See prognosis below VIII. Management: Overall treatment strategy Non-Keratinized Warts First line: or Alternative: Refractory: , TCA, ablation Keratinized warts First line Warts <10 mm: Warts >10 mm: Surgical excision (or if persistent) Adjunctive: applied as pretreatment Warts on mucosal surface (Vagina, , anal) First line: Alternative: Trichloroacetic Acid Pregnancy Indications for HPV treatment in pregnancy Treat only lesions that would obstruct labor or result in significant (...) Solution is left on skin for 1-4 hours and then washed off Similar clearance rates and recurrence to self applied agents listed above FDA category X Toxicity risk (deaths have occurred) Limit application area to <10 cm^2 Limit amount applied to <0.5 ml per treatment Trichloroacetic acid (TCA) 60-90% compounded solution (or Bichloroacetic Acetic Acid or BCA) Apply to each wart up to three times weekly until resolution Allow to dry (lesion will "frost" or turn white) Solution is liquidy and easily

2018 FP Notebook

150. Wart Immune Therapy

: Wart Immune Therapy , Intralesional Candida Injection From Related Chapters II. Indication s refractory to other treatments Not FDA approved (anecdotal support only) III. Preparation Killed Candida (Monilia albicans) Used in Manitou control (1:1000 solution) IV. Application Preparation Mix equal parts of 1% without Use 30 gauge needle Choose largest wart Injection Inject 0.1 cc to 0.3 cc intradermal beside wart Wart should blanche with injection V. Precautions Wear protective glasses Limit to 3 (...) Wart Immune Therapy Wart Immune Therapy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Wart Immune Therapy Wart Immune Therapy Aka

2018 FP Notebook

151. Trends in genital warts due to the quadrivalent human papillomavirus vaccination: a meta-analysis

Trends in genital warts due to the quadrivalent human papillomavirus vaccination: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address (...) is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size), and that the true effect is the same (fixed) across all studies. However, this assumption is unlikely to hold true for data from animal studies, which generally include various species, strains and treatment regimes, for which different true effects are likely to exist

2018 PROSPERO

152. Impact and effectiveness of the human papillomavirus (HPV) vaccine on anogenital warts in United States and Canada: a systematic review

Impact and effectiveness of the human papillomavirus (HPV) vaccine on anogenital warts in United States and Canada: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne (...) . ">Effect measure The random-effects model is the typical model of choice for pre-clinical meta-analyses. This is because in the fixed-effect model, it is assumed that the differences in observed effect between studies is solely due to sampling error (i.e. differences in sample size), and that the true effect is the same (fixed) across all studies. However, this assumption is unlikely to hold true for data from animal studies, which generally include various species, strains and treatment regimes

2018 PROSPERO

153. Bismuth Injections in the Treatment of Warts: Report of Bismuth Injections in the Treatment of Sixty-One Cases of Warts at the Cowell Memorial Hospital of the University of California Full Text available with Trip Pro

Bismuth Injections in the Treatment of Warts: Report of Bismuth Injections in the Treatment of Sixty-One Cases of Warts at the Cowell Memorial Hospital of the University of California 18742710 2008 08 29 2008 11 20 0093-4038 39 6 1933 Dec California and western medicine Cal West Med Bismuth Injections in the Treatment of Warts: Report of Bismuth Injections in the Treatment of Sixty-One Cases of Warts at the Cowell Memorial Hospital of the University of California. 385-8 Lunsford C J CJ Thomson

1933 California and western medicine

154. Treatment of external genital warts and pre-invasive neoplasia of the lower tract. In: Canadian consensus guidelines on human papillomavirus.

Treatment of external genital warts and pre-invasive neoplasia of the lower tract. In: Canadian consensus guidelines on human papillomavirus. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research

2009 Society of Obstetricians and Gynaecologists of Canada

155. Interferon for the treatment of genital warts: a systematic review

Interferon for the treatment of genital warts: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

156. High prevalence of cutaneous warts in elementary school children and ubiquitous presence of wart-associated HPV on clinically normal skin. (Abstract)

High prevalence of cutaneous warts in elementary school children and ubiquitous presence of wart-associated HPV on clinically normal skin. One-third of Dutch primary school children have cutaneous warts; each year around 20% of them seek medical treatment. However, little is known about the epidemiology of the types of human papillomavirus (HPV) causing these warts.To investigate the distribution of cutaneous wart-associated HPV types in three primary school classes by analysing skin swabs (...) taken from warts, and the forehead, hand dorsum and sole of the foot of included children.Using the hyperkeratotic skin lesion polymerase chain reaction/multiplex genotyping assay, each swab sample was used to genotype for 23 cutaneous wart-associated HPV types.Thirty-one (44%) of the 71 children had a total of 69 warts, with a maximum of six warts per child. In the wart swabs, HPV2, HPV27 and HPV57, members of Alphapapillomavirus species 4, were most frequently detected (27%, 32% and 14

2014 British Journal of Dermatology

157. Efficacy of Myrtus communis L. and Descurainia sophia L. Versus Salicylic Acid for Wart Treatment Full Text available with Trip Pro

Efficacy of Myrtus communis L. and Descurainia sophia L. Versus Salicylic Acid for Wart Treatment Wart is a skin disease with circular appendages, which is called "suloul" in Iranian traditional medicine (ITM). According to ITM literature, warts have different types and causes. The most important mechanism is excretion of materials (Khelt) from body to skin and mucus; its causative material is often phlegm, black bile or a combination of them. To treat warts, it is necessary to consider (...) groups (P < 0.001). Relapse was not seen in any groups after three months. The frequency of side effects was similar after three months.M. communis L. can be used as a topical treatment for warts. It not only shows more rapid response than salicylic acid, but also has fewer side effects. It seems that D. sophia L. can modify the digestion process and patients can excrete large amounts of the substance that causes warts. Therefore, it is better to use it more than 40 days. According to our

2014 Iranian Red Crescent medical journal Controlled trial quality: uncertain

158. Subcutaneous intralesional Ksharodaka injection: A novel treatment for the management of Warts: A case series Full Text available with Trip Pro

Subcutaneous intralesional Ksharodaka injection: A novel treatment for the management of Warts: A case series Warts are generally managed using cryosurgery, keratolytic ointments, curettage and electrodessication. Warts, vis-a-vis Charmakila, in Ayurvedic classical texts are classified into different types depending on the dominance of dosha. Ayurveda prescribes oral medications, topical use of Kshara (alkaline ash of herbs), Agni (thermal cautery) and Shastrakarma (surgery) for removal (...) of Charmakila. Use of topical Kshara in the form of powder, aqueous solution i.e. Ksharodaka and Ksharasutra (thread smeared with Kshara) for warts has been reported. However, these methods necessitate multiple sittings and takea longer duration for removal of the warts. Herewith, we report a case series of different types of warts treated with intralesional infiltration of Apamarga Ksharodaka (AK), i.e. aqueous solution of Apamarga (Achyranthes aspera) Kshara. We observed that all these warts took

2014 Journal of Ayurveda and integrative medicine

159. Imiquimod in the treatment of cutaneous warts: an evidence-based review. (Abstract)

Imiquimod in the treatment of cutaneous warts: an evidence-based review. Cutaneous warts are highly prevalent lesions caused by the infection of keratinocytes by different types of human papillomaviruses. Although cutaneous warts are capable of resolving spontaneously, these infections can persist for long periods of time by evading the host immune system, and, as a result, many patients choose to seek treatment. Imiquimod is an immune response modifier that is approved as a topical cream (...) for the treatment of anogenital warts by the US Food and Drug Administration. However, the efficacy of imiquimod in the treatment of cutaneous warts has not been well established.The purpose of this article is to systematically review the published literature regarding the efficacy of imiquimod in the treatment of cutaneous warts, and to evaluate the quality and outcomes of these studies.A literature search was performed through clinical queries PubMed (National Library of Medicine) database and the Cochrane

2014 American journal of clinical dermatology

160. Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. (Abstract)

Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. 24566576 2014 06 02 2014 09 26 0392-0488 149 1 2014 Feb Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia G Ital Dermatol Venereol Comparison of efficacy of 5% potassium hydroxide solution versus cryotherapy in the treatment of male genital wart: a randomized clinical trial. 149-50

2014 Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>